Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study
Toxins · 2025
DOI: 10.3390/toxins17050220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Hye-Ji Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Temporomandibular Joint Disorders, Neuromuscular Agents, Masticatory Muscles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Botulinum toxin type A (BoNT-A), a potent neurotoxin, is increasingly used to treat myogenic temporomandibular disorders (TMDs); however, the interplay between muscle atrophy and pain relief remains incompletely understood. This pilot study investigated how masseter and temporalis muscle thickness and pain intensity change over 12 weeks following BoNT-A injections in 15 patients (mean age 51.42 years) with myogenic TMD. Muscle thickness was measured via ultrasonography across multiple anatomical positions under both clenching and resting conditions at baseline and at 2, 4, 8, and 12 weeks post-injection. Significant thinning of both muscles occurred within 2 weeks, lasting until 12 weeks, but became less pronounced after the first month. Pain intensity showed parallel decreases, most notably early on, but these reductions were not consistently statistically significant. Correlation analyses revealed no strong persistent association between muscle thickness and pain except for a moderately positive correlation in the anterior temporalis at two weeks (r = 0.61, p = 0.04). BoNT-A induces rapid masticatory muscle atrophy and modest pain relief; however, these outcomes do not coincide. Pain relief was observed earlier than the full development of muscle atrophy and should be considered during TMD pain management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Medicine, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
- Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul 03722, Republic of Korea.
- Department of Oral and Maxillofacial Surgery, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.
ORCID-Profile: Hye-Ji Park, Hee-Jin Kim, Sung Ok Hong
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, H. J., Kim, H. J., & Hong, S. O. (2025). Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study. Toxins. https://doi.org/10.3390/toxins17050220
Vancouver
Park HJ, Kim HJ, Hong SO. Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study. Toxins. 2025. doi:10.3390/toxins17050220
BibTeX
@article{Park2025,
author = {Park, Hye-Ji and Kim, Hee-Jin and Hong, Sung Ok},
title = {Is There a Correlation Between Masticatory Muscle Thickness and Pain After Botulinum Toxin Injections in Myogenic TMD Patients?: A Pilot Study},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17050220}
}
EUVIMED